Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Omega-3 fatty acids for bipolar disorder
Your Article Summary
See Latest ArticlesMale methamphetamine-user inmates in prison treatment: During-treatment outcomes
Journal of Substance Abuse Treatment, 10/09/09
Joe GW et al. – Significant predictors of treatment progress included baseline psychosocial functioning and background, wherein higher psychosocial functioning and lower criminal thinking orientation predicted stronger therapeutic engagement. However, treatment engagement level was found to mediate during–treatment improvement and initial criminal thinking.
Today in Other Psychiatry...keeping you current
Receive free subspecialty "5-minute updates" via email
Is Monotherapy as Good as Polypharmacy in Long-Term Treatment of Bipolar Disorder
Canadian Journal of Psychiatry, 11/16/09
Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents
JAMA, 10/28/09
Asenapine versus olanzapine in acute mania: a double-blind extension study
Bipolar Disorders, 10/22/09
Today in Substance Abuse...keeping you current
Receive free subspecialty "5-minute updates" via email
Estimation of clonazepam abuse liability: a new method using a reimbursed drug database
International Clinical Psychopharmacology, 10/20/09
Drug use and addiction: evolutionary perspective
Australian and New Zealand Journal of Psychiatry, 11/04/09
Tobacco as a Substance of Abuse
Pediatrics, 11/05/09
Sponsor
Article Search
Sponsor